CAMBRIDGE NUTRITIONAL SCIENCES PLC Cambridge Nutritional Sciences plc Stock
Equities
ODX
GB00B1VCP282
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.85 GBX | -3.75% |
|
+18.46% | +60.42% |
| Apr. 22 | Cambridge Nutritional Sciences Nonexecutive Chair Steps Down; Successor Named | MT |
| Apr. 22 | Cambridge Nutritional Sciences plc Provides Earnings Guidance for the Year Ended 31 March 2024 | CI |
| Sales 2024 * | 9M 11.26M | Sales 2025 * | - | Capitalization | 9.52M 11.91M |
|---|---|---|---|---|---|
| Net income 2024 * | -1M -1.25M | Net income 2025 * | - | EV / Sales 2024 * | 0.59 x |
| Net cash position 2024 * | 4.2M 5.26M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
| P/E ratio 2024 * |
-8
x | P/E ratio 2025 * |
-
| Employees | 91 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.83% |
More Fundamentals
* Assessed data
More news
Latest transcript on Cambridge Nutritional Sciences plc
More press releases
| 1 day | -4.75% | ||
| 1 week | +17.23% | ||
| Current month | +10.43% | ||
| 1 month | +15.45% | ||
| 3 months | +58.75% | ||
| 6 months | +111.67% | ||
| Current year | +58.75% |
1 week
3.28
4.17
1 month
3.204.17
Current year
2.304.17
1 year
1.664.17
3 years
1.6688.80
5 years
1.66126.95
10 years
1.66126.95
| Managers | Title | Age | Since |
|---|---|---|---|
Jag Grewal
CEO | Chief Executive Officer | 54 | 11-06-29 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jag Grewal
CEO | Chief Executive Officer | 54 | 11-06-29 |
Jeremy Millard
BRD | Director/Board Member | 53 | 19-02-28 |
Carolyn Rand
CHM | Chairman | 60 | 23-08-16 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 3.85 | -3.75% | 1 184 714 |
| 24-04-24 | 4 | 0.00% | 1,861,453 |
| 24-04-23 | 4 | +8.11% | 3,100,431 |
| 24-04-22 | 3.7 | +13.85% | 4,653,177 |
| 24-04-19 | 3.25 | 0.00% | 9,898 |
Delayed Quote London S.E., April 25, 2024 at 07:23 am EDT
More quotes
Cambridge Nutritional Sciences plc is a United Kingdom-based specialist medical diagnostics company. The Company develops, manufactures and markets diagnostic products associated with food sensitivity and gut health. The Company serves healthcare professionals and the consumer directly with a focus on health and nutrition products.
Calendar
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +58.75% | 11.83M | |
| -0.80% | 12.72B | |
| -11.57% | 7.5B | |
| +2.40% | 5.48B | |
| +0.98% | 4.61B | |
| +5.18% | 4.47B | |
| -50.82% | 3.28B | |
| +11.23% | 2.71B | |
| -18.23% | 2.02B | |
| -10.84% | 1.74B |
- Stock Market
- Equities
- ODX Stock
